Qube Research & Technologies LTD Axsome Therapeutics, Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 155,911 shares of AXSM stock, worth $18.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
155,911
Previous 30,370
413.37%
Holding current value
$18.6 Million
Previous $2.73 Million
383.54%
% of portfolio
0.02%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$484 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$466 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$394 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$176 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$166 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.12B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...